1. Hafler DA. Multiple sclerosis. J Clin Invest. 2004 Mar;113(6):788-94. doi: 10.1172/JCI21357. [ DOI] [ PubMed] 2. Gourraud PA, Harbo HF, Hauser SL, Baranzini SE. The genetics of multiple sclerosis: an up-to-date review. Immunol Rev. 2012 Jul;248(1):87-103. doi: 10.1111/j.1600-065X.2012.01134.x. [ DOI] [ PubMed] 3. Kasper DL, Braunwald E, Hauser S, Longo D, Jameson JL, Fauci AS. Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill Professional. 2004; pp: 2461-71. 4. Hoffmann V, Pöhlau D, Przuntek H, Epplen JT, Hardt C. A null mutation within the ciliary neurotrophic factor (CNTF)-gene: implications for susceptibility and disease severity in patients with multiple sclerosis. Genes Immun. 2002 Feb;3(1):53-55. doi: 10.1038/sj.gene.6363818. [ DOI] [ PubMed] 5. Vinayak R. Chemical synthesis, analysis, and purification of ribozymes. Methods Mol Biol. 1997;74:51-58. doi: 10.1385/0-89603-389-9:51. [ DOI] [ PubMed] 6. Larson EB, Burnison DS, Brown WS. Callosal function in multiple sclerosis: bimanual motor coordination. Cortex. 2002 Apr;38(2):201-14. doi: 10.1016/s0010-9452(08)70650-6. [ DOI] [ PubMed] 7. Gronwall DM. Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills. 1977 Apr;44(2):367-73. doi: 10.2466/pms.1977.44.2.367. [ DOI] [ PubMed] 8. Williams PL, Warwick R, Dyson M, Bannister LH. Gray's anatomy. 37th ed. London: Churchill Livingstone. 1989. 9. Audoin B, Ibarrola D, Malikova I, Soulier E, Confort-Gouny S, Duong MV, et al. Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis--a two-year longitudinal MRI/MRSI study of corpus callosum. Mult Scler. 2007 Jan;13(1):41-51. doi: 10.1177/1352458506071215. [ DOI] [ PubMed] 10. Kubaszek A, Pihlajamäki J, Punnonen K, Karhapää P, Vauhkonen I, Laakso M. The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. Diabetes. 2003 Feb;52(2):558-61. doi: 10.2337/diabetes.52.2.558. [ DOI] [ PubMed] 11. Galun E, Nahor O, Eid A, Jurim O, Rose-John S, Blum HE, et al. Human interleukin-6 facilitates hepatitis B virus infection in vitro and in vivo. Virology. 2000 May;270(2):299-309. doi: 10.1006/viro.2000.0210. [ DOI] [ PubMed] 12. Kakumu S, Shinagawa T, Ishikawa T, Yoshioka K, Wakita T, Ida N. Interleukin 6 production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection and primary biliary cirrhosis. Gastroenterol Jpn. 1993 Feb;28(1):18-24. doi: 10.1007/BF02774999. [ DOI] [ PubMed] 13. van der Poll T, Keogh CV, Guirao X, Buurman WA, Kopf M, Lowry SF. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis. 1997 Aug;176(2):439-44. doi: 10.1086/514062. [ DOI] [ PubMed] 14. Maimone D, Guazzi GC, Annunziata P. IL-6 detection in multiple sclerosis brain. J Neurol Sci. 1997 Feb;146(1):59-65. doi: 10.1016/s0022-510x(96)00283-3. [ DOI] [ PubMed] 15. van Boxel-Dezaire AH, Hoff SC, van Oosten BW, Verweij CL, Dräger AM, Adèr HJ, et al. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann Neurol. 1999 Jun;45(6):695-703. doi: 10.1002/1531-8249(199906)45:6<695::aid-ana3>3.0.co;2-r. [ DOI] [ PubMed] 16. Petereit HF, Pukrop R, Fazekas F, Bamborschke SU, Röpele S, Kölmel HW, et al. Low interleukin-10 production is associated with higher disability and MRI lesion load in secondary progressive multiple sclerosis. J Neurol Sci. 2003 Feb;206(2):209-14. doi: 10.1016/s0022-510x(02)00420-3. [ DOI] [ PubMed] 17. Waubant E, Gee L, Bacchetti P, Sloan R, Cotleur A, Rudick R, et al. Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS. J Neuroimmunol. 2001 Jan;112(1-2):139-45. doi: 10.1016/s0165-5728(00)00355-6. [ DOI] [ PubMed] 18. Nouri Hosseini H, Mohammadi MR, Aarabi M, Mohammadi N, Golalipour MJ. Ethnicity Influences Corpus Callosum Dimensions. Neurol Res Int. 2018 May;2018:8916035. doi: 10.1155/2018/8916035. [ DOI] [ PubMed] 19. Pourhossein M, Ghavimi R, Alsahebfosoul F, Ghaedi K. Association between rs1800795 (-174 G/C) Polymorphism in the Promoter of IL6 Gene and Risk of Relapsing-Remitting Multiple Sclerosis (RRMS) in Isfahan Population. Open Journal of Genetics. 2014;4(5):407-13. doi: 10.4236/ojgen.2014.45038. [ Link] [ DOI] 20. Hu S, Chen Y, Sun XD, Li FJ, Shu QF, Liu XL, Jiang SF. Association between IL-6-174G/C polymorphism and risk of multiple sclerosis: a meta-analysis. Genet Test Mol Biomarkers. 2014 Feb;18(2):127-30. doi: 10.1089/gtmb.2013.0387. [ DOI] [ PubMed] 21. Llufriu S, Blanco Y, Martinez-Heras E, Casanova-Molla J, Gabilondo I, Sepulveda M, et al. Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study. PLoS One. 2012;7(5):e37167. doi: 10.1371/journal.pone.0037167. [ DOI] [ PubMed] 22. Azarpira N, Borhani Haghighi A, Pourjafar M, Shariat A. Interleukin 10 gene polymorphism in Iranian patients with multiple sclerosis. Acta Neurol Taiwan. 2010 Jun;19(2):107-11. [ PubMed] 23. Mihailova S, Ivanova M, Mihaylova A, Quin L, Mikova O, Naumova E. Pro- and anti-inflammatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients. J Neuroimmunol. 2005 Nov;168(1-2):138-43. doi: 10.1016/j.jneuroim.2005.06.020. [ DOI] [ PubMed] 24. Azadi M, alsahebfosoul F, Salehi R, Tajbakhsh E, Etemadifar M. [Investigation of genetic variation of IL-4 receptor rs1801275 in patients with multiple sclerosis in Isfahan]. NCMBJ. 2019;9(34):93-102. [Article in Persian] [ Link] 25. Jamali M, Rostami Rad M, Anani Sarab G, Mahdavi R. [IL-33 polymorphism rs1929992 and its association with susceptibility to different pattern of multiple sclerosis]. Tehran Univ Med J. 2018;76(7):446-51. [Article in Persian] [ Link] 26. Seyfizadeh N, Kazemi T, Farhoudi M, Aliparasti MR, Sadeghi-Bazargani H, et al. Association of IL-13 single nucleotide polymorphisms in Iranian patients to multiple sclerosis. Am J Clin Exp Immunol. 2014 Dec 5;3(3):124-29. [ PubMed] 27. Bakr NM, Hashim NA, El-Baz HAE, Khalaf EM, Elharoun AS. Polymorphisms in proinflammatory cytokines genes and susceptibility to Multiple Sclerosis. Mult Scler Relat Disord. 2021 Jan;47:102654. doi: 10.1016/j.msard.2020.102654. [ DOI] [ PubMed] 28. Sayad A, Movafagh A. The association of -330 interleukin-2 gene polymorphism with its plasma concentration in Iranian multiple sclerosis patients. Scientifica (Cairo). 2014;2014:724653. doi: 10.1155/2014/724653. [ DOI] [ PubMed] 29. Simsek H, Geckin H, Sensoz NP, List EO, Arman A. Association Between IL7R Promoter Polymorphisms and Multiple Sclerosis in Turkish Population. J Mol Neurosci. 2019 Jan;67(1):38-47. doi: 10.1007/s12031-018-1205-0. [ DOI] [ PubMed] 30. Majdinasab N, Hosseini Behbahani M, Galehdari H, Mohaghegh M. Association of interleukin 7 receptor gene polymorphism rs6897932 with multiple sclerosis patients in Khuzestan. Iran J Neurol. 2014 Jul;13(3):168-71. [ PubMed] |
